Kaidar-Person O, Amit A, Berniger A, Ben-Yosef R, Kuten A, Bortnyak-Abdah R
Division of Oncology, Rambam Health Care Campus, Haifa, Israel.
Eur J Gynaecol Oncol. 2013;34(4):353-4.
Signet-ring cell adenocarcinoma is a rare subtype of the uterine cervix; thus there are no guidelines and the prognosis is unknown. There seems to be a significant role for reporting the treatment and outcome of this rare disease in order to establish guidelines and to assist in decision-making. However, treatment should be tailored to each patient according to clinical status and disease stage. Excluding extra-genital origin is mandatory, as it will change treatment management considerably.
印戒细胞腺癌是子宫颈的一种罕见亚型；因此没有相关指南，其预后也未知。报告这种罕见疾病的治疗情况和结果对于制定指南及辅助决策似乎具有重要作用。然而，治疗应根据每位患者的临床状况和疾病分期进行个体化调整。必须排除生殖器外起源，因为这会显著改变治疗方案。
